Cancer Drug Market Evolves - Cannabis

New Post Public Reply Private Reply Replies (1) Message Board
Roger Wilco

Cancer Drug Market Evolves - Cannabis Science and ARIAD Pharmaceuticals Poised to Benefit

Date : 02/27/2012 @ 8:20AM
Source : MarketWire
Stock : Paragon Financial Limited (CBIS)
Quote : 0.091  0.003 (3.41%) @ 10:28AM

Cancer Drug Market Evolves - Cannabis Science and ARIAD Pharmaceuticals Poised to Benefit

Cannabis Science (OTCBB:CBIS)
Intraday Stock Chart

Today : Monday 27 February 2012

Click Here for more Cannabis Science Charts.

Advances in cancer screening and treatment has caused the death rate from cancer to drop dramatically in recent years. Cancer death rates dropped by 1.8 percent per year in men and 1.6 percent per year in women between 2004 and 2008, according to the American Cancer Society's annual report on cancer statistics. The Paragon Report examines investing opportunities in the Healthcare sector and provides equity research on Cannabis Science Inc. (OTCBB: CBIS) & ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA). Access to the full company reports can be found at:

www.paragonreport.com/CBIS

www.paragonreport.com/ARIA

Death rates fell in all four of the most common cancers, lung, colon, breast and prostate, with lung cancer accounting for nearly 40 percent of the total drop in men and breast cancer account for 34 percent of the total decline in women, the American Cancer Society report finds.

The U.S. FDA has been approving cancer drugs at a faster rate than its European counterpart (the EMA), Friends of Cancer Research reports. Between 2003 and 2010, the FDA not only approved more new cancer drugs than did the EMA, it approved these drugs more quickly: of 23 drugs approved by both agencies, the median time from marketing submission to FDA approval was 182 days vs. EMA approval of 350 days according to the report.

The Paragon Report provides investors with an excellent first step in their due diligence by providing daily trading ideas, and consolidating the public information available on them. For more investment research on the Healthcare sector register with us free at www.paragonreport.com and get exclusive access to our numerous stock reports and industry newsletters.

ARIAD Pharmaceuticals' product pipeline includes Ponatinib, a pan BCR-ABL inhibitor in phase 2 clinical trial for applications in various hematological cancers and solid tumors; and AP26113, an anaplastic lymphoma kinase (ALK) inhibitor in preclinical studies for the treatment of various cancers, including non-small cell lung cancer, lymphoma, and neuroblastoma.

Cannabis Science, Inc., a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products. Earlier this month the company introduced a fourth cancer patient with basal cell carcinoma (skin cancer) on his left nostril, who is self-administering a topical cannabis extract and having noticeable results.

The Paragon Report has not been compensated by any of the above-mentioned publicly traded companies. Paragon Report is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at http://www.paragonreport.com/disclaimer

Scroll down for more posts ▼

Top 10 Most Recent News Articles

World Treadmill Championship: A New Run Begins

Updated Category News Views 2

A Run Like No Other I’ll bet you’ve heard it all when it comes to races—winding city marathons, grueling ultras with rough terrain, and everything in between. But a world championship on treadmills? Now that's a fresh spin! October 23rd, 2026 is when the RUN X™ World Treadmill Championship kicks off, stretching out across the planet in 400 fitness centres...

Continue Reading
MSG Rangers Joining S&P SmallCap 600: Key Moves

Updated Category News Views 5

MSG Rangers Takes Center Ice—In the Market Here we go—MSG Rangers (NYSE: MSGR) is sliding into the S&P SmallCap 600 like a puck on fresh ice, ready to switch places with Arbor Realty Trust (NYSE: ABR) come October 27. Now, that's not just a game changer for MSGR, but also throws some shuffle onto the board for investors in these organizations. We've got Madison Square...

Continue Reading
Ellington's Q3 Earnings Call: What Investors Need to Know

Updated Category News Views 3

An Anticipated Unveiling Ellington Financial Inc. (NYSE:EFC) is gearing up to spill the beans on its third-quarter financials for 2026. It's all going down after the markets close on November 4th. I can tell you, folks, anyone keeping an eye on EFC will be itching to know what's inside those numbers. With a company this deep into financial assets, reading between the...

Continue Reading
Tajín's Chamoy Twist: Spice Up Everyday Treats

Updated Category News Views 5

A New Flavor Adventure Lands on Aisles Alright, folks, nothing quite spices up a mundane snack session like a new sauce from a brand with serious street cred. Tajín's latest brainchild, the Twist Chamoy Sauce, just hit a retailer near you. It's promising to take your tastebuds on a rollercoaster ride—no ticket needed, just a generous pour over whatever munchies you're...

Continue Reading
Lyric Health's Grace: Transforming Virtual Healthcare

Updated Category News Views 9

Grace in the Spotlight: A Game-Changer in Virtual Healthcare If you're tired of healthcare tech making big promises and delivering little, this might pique your interest. Lyric Health has rolled out Grace, a multimodal AI addition to their Virtual Care Operating System. This isn’t your run-of-the-mill chatbot — it’s a blend of proactive health monitoring,...

Continue Reading
Saab Q3 2026: Major Contracts Fuel Impressive Growth

Updated Category News Views 3

Saab's Stellar Q3 Performance If there’s one picture capturing the essence of Saab’s third quarter in 2026, it's one brimming with contracts, cash, and sheer growth. They’re racking up tangible wins left and right, and if you're an investor who loves numbers doing a solid 30.6% high jump, Saab's buzzing red-hot. Key Contracts Putting Saab in the Spotlight The very...

Continue Reading
TTMI Under Scrutiny: Ademi LLP's Fraud Investigation

Updated Category News Views 0

Ademi LLP Puts TTMI in the Spotlight If you blinked, you might have missed it, but TTM Technologies, listed on NASDAQ as TTMI, has taken a nosedive recently—shedding over 25% of its stock value in what’s proving to be a hot mess for its shareholders. The cherry on top? Ademi LLP is rolling up its sleeves for an investigation into what looks like a tangled web of...

Continue Reading
FM's Bold $855M Resilience Credit: A Game Changer

Updated Category News Views 5

Breaking Down the US$855 Million Payout Just when you think you’ve got the insurance landscape figured out, FM spins the wheel with a US$855 million resilience credit, all thanks to its mutual structure and healthy results. Let’s unpack this hefty premium offset, shall we? A Second Year of Solid Savings This isn’t FM’s first rodeo. We're talking about a 10%...

Continue Reading
Country Stars Illuminate Art in Philly, Mississippi

Updated Category News Views 3

A Mural Tribute to Country Music Roots Forget about skyscrapers and bustling metropolises; sometimes, it's about bringing a bit of soul back to the heartland. That's precisely what the unveiling of the "Wildflowers and Wild Horses" mural in Philadelphia, Mississippi, did. Lainey Wilson and Marty Stuart's Vision Partners in crime — or, more fittingly, in country —...

Continue Reading
Wood Coatings Market Set for Sustainable Surge by 2032

Updated Category News Views 1

Riding the Wave of Sustainable Coatings Who'd have thought we'd be chatting about wood coatings making such a splash? Turns out, this unsung hero of the materials world is gearing up for some serious growth, with the market projected to hit a crisp $33.34 billion by 2032. That's a decent jump from where it stands today, and it's all thanks to the shift towards...

Continue Reading

Top 5 Most Recently Viewed Articles

Outset Medical Successfully Resolves FDA Warning Letter Issues

Updated Category News Views 109

Outset Medical Resolves Important Regulatory Issues Outset Medical, Inc. (NASDAQ: OM), a leading innovator in medical technologies for dialysis, recently announced significant progress in addressing the issues outlined in a Warning Letter from the Food and Drug Administration (FDA). This notification reflects Outset's commitment to high standards and continuous...

Continue Reading
Mawson Infrastructure Group's Recent Court Dismissal Update

Updated Category News Views 104

Mawson Infrastructure Group Gains Court Dismissal for Bankruptcy Petition Mawson Infrastructure Group Inc. (NASDAQ: MIGI), a prominent technology firm, has recently celebrated a significant legal victory. This victory comes in the form of a formal ruling from the United States Bankruptcy Court, which dismissed an involuntarily filed bankruptcy petition against the...

Continue Reading
Northeast Indiana Bancorp Boosts Dividend for Shareholders Again

Updated Category News Views 138

Northeast Indiana Bancorp Increases Quarterly Cash Dividend The Board of Directors of Northeast Indiana Bancorp, Inc. (OTCQB: NIDB) has proudly announced an increase in the cash dividend for shareholders, marking the corporation's 31st consecutive year of rewarding its investors. This remarkable achievement reflects the company's sustained financial performance and...

Continue Reading
Discover the Richness of European Wines at Upcoming NYC Event

Updated Category News Views 120

Experience Exceptional Quality Wines from Europe Renowned Italian and Spanish institutions are collaborating to raise awareness of the PDO and PGI European Quality Schemes through an engaging new initiative. The program, tastefully named "Taste the Difference: Quality Wines from the Heart of Europe," will once again enchant wine lovers in the United States with an array...

Continue Reading
CarMax Faces Class Action Lawsuit: Key Dates and Details

Updated Category News Views 182

Overview of the CarMax Class Action Lawsuit New York, a leading securities law firm has revealed that a class action lawsuit has been initiated against CarMax, Inc. (NYSE: KMX) and specific senior executives of the company for allegations of securities fraud. This development arises after a notable drop in stock price attributed to possible violations of federal...

Continue Reading